Xperiome

Xperiome is a global healthtech company founded in 2015 and headquartered in the United Kingdom. The company's slogan "Get to know rare disease patients" reflects its core mission. Xperiome aims to provide deep insights into the patient experience by creating Raremark, a platform that serves as a community for rare disease patients. Raremark offers various resources, including a community to source wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities.

One of the key highlights of Xperiome is its data-driven knowledge bank, which enables the matching of research-ready members to clinical and real-world studies. This approach accelerates the process of accessing rare disease patients for research, faster and smarter than ever before.

Notably, Xperiome secured a significant £3.00M Series A investment on 22 October 2018, with contributions from Ananda Impact Ventures, Oltre Venture, Albion VC, Cass Entrepreneurship Fund, and SyndicateRoom. This investment underscores the confidence of prominent investors in Xperiome's innovative approach to addressing the needs of rare disease patients and the pharmaceutical industry.